The influence of oral contraceptives on athletic performance in female athletes

Sports Medicine

Volumn 37, Issue 7, 2007, Pages 557-574

  Burrows, Melonie ^a,b   Peters, Charlotte E ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BREVNOR; DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; DIANE; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS ETYNODIOL DIACETATE; ETHINYLESTRADIOL PLUS GESTODENE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL PLUS NORGESTIMATE; ETYNODIOL; FEMODETTE; GESTAGEN; LEVONORGESTREL; MESTRANOL PLUS NORETHISTERONE; MINOVRAL; NEOGENTROL; NORETHISTERONE; NORGESTIMATE; NORGESTREL; ORAL CONTRACEPTIVE AGENT; ORTHO TRIC CYCLEN; PLACEBO; PROGESTERONE; SEX HORMONE; STERDIRIL M; TRI MINULET; UNCLASSIFIED DRUG;

ATHLETE; BREAST TENDERNESS; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; FEMALE; HUMAN; HUMAN EXPERIMENT; MEDICAL RESEARCH; MENSTRUAL CYCLE; MOTOR PERFORMANCE; NAUSEA; NORMAL HUMAN; ORAL CONTRACEPTION; REVIEW;

ADULT; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; GREAT BRITAIN; HUMANS; SPORTS; TASK PERFORMANCE AND ANALYSIS;

EID: 34347392652     PISSN: 01121642     EISSN: None     Source Type: Journal    
DOI: 10.2165/00007256-200737070-00001     Document Type: Review

References (66)

1. Bennell K, White S, Crossley K. The oral contraceptive pill: a revolution for sportswomen? Br J Sports Med 1999; 33: 231-8
2. Lebrun CM. Effects of the menstrual cycle and oral contraceptives on sports performance. In: Drinkwater BL, editor. Women in sport. Oxford: Blackwell Science Ltd, 2000: 37-61
3. Akin JW. Contraception. In: Ireland ML, Nattiv A, editors. The female athlete. Philadelphia (PA): Saunders, 2002: 157-64
4. Kuhl H. Comparative pharmacology of newer progestogens. Drugs 1996; 51 (2): 188-215
5. Lebrun CM, Petit MA, McKenzie DC, et al. Decreased maximal aerobic capacity with use of a triphasic oral contraceptive in highly active women: a randomised controlled trial. Br J Sports Med 2003; 37: 315-20
6. Greydanus DE, Louchamp D. Contraception in the adolescent: preparation for the 1990s. Med Clin North Am 1990; 74: 1205-24
7. Rosenberg MJ, Meyers A, Roy V. Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20μg and 35μg oestrogen preparations. Contraception 2000; 60: 321-9
8. Tortora GJ, Grabowski SR. Principles of anatomy and physiology. New York: John Wiley and Sons Inc., 2003
9. Carr BR. Uniqueness of oral contraceptive progestins. Contraception, 1998; 58: S23-7
10. Scharnagl H, Petersen G, Nauck M, et al. Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20μg or 30μg) and levonorgestrel (100μg or 150μg) of lipoprotein metabolism. Contraception 2004; 69: 105-13
11. Phillips A, Demarest K, Hahn DW, et al. Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins. Contraception 1990; 41: 399-41
12. Greer JB, Modugno F, Allen GO, et al. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer. Obstet Gynecol 2005; 105: 731-40
13. LaGuardia KD, Shangold G, Fisher A, et al. Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol. Contraception 2003; 67: 431-7
14. Redman LM, Weatherby RP. Measuring performance during the menstrual cycle: a model using oral contraceptives. Med Sci Sports Exerc 2004; 36: 130-6
15. Fotherby K. Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapy. Contraception 1996; 54: 59-69
16. Constantini NW, Dubnou G, Lebrun CM. The menstrual cycle and performance. Clin Sports Med 2005; 24: 51-82
17. McNeil AW, Mozingo E. Changes in the metabolic cost of standardised work associated with the use of an oral contraceptive. J Sports Med 1981; 21: 238-44
18. Montes A, Lally D, Hale RW. The effects of oral contraceptives on respiration. Fertil Steril 1983; 39 (4): 515-9
19. Notelovitz M, Zauner C, McKenzie L, et al. The effect of low-dose contraceptives on cardiorespiratory function, coagulation, and lipids in exercising young women: a preliminary report. Am J Obstet Gynecol 1987; 156: 591-8
20. Bonen A, Haynes FW, Graham TE. Substrate and hormonal response to exercise in women using oral contraceptives. J Appl Physiol 1991; 70 (5): 1917-27
21. Bemben DA, Boileau RA, Bahr JM, et al. Effects of oral contraceptives on hormonal and metabolic responses during exercise. Med Sci Sports Exerc 1992; 24 (2): 434-41
22. Grucza R, Pekkarinen H, Titov EK, et al. Influence of the menstrual cycle and oral contraceptives on thermoregulatory responses to exercise in young women. Eur J Appl Physiol 1993; 67: 279-85
23. Sarwar R, Nicols BB, Rutherford OM. Changes in muscle strength, relaxation rate and fatiguability during the human menstrual cycle. J Physiol 1996; 493 (1): 267-72
24. Rogers SM, Baker MA. Thermoregulation during exercise in women who are taking oral contraceptives. Eur J Appl Physiol 1997; 75: 34-8
25. Thompson HS, Hyatt JP, De-Souza MJ, et al. The effects of oral contraceptives on delayed onset muscle soreness following exercise. Contraception 1997; 56: 59-65
26. Lynch NJ, Nimmo MA. Effects of menstrual cycle phase and oral contraceptive use on intermittent exercise. Eur J Appl Physiol 1998; 78: 565-72
27. Giacomoni M, Falgairette G. Decreased submaximal oxygen uptake during short duration oral contraceptive use: a randomised cross-over trial in premenopausal women. Ergonomics 2000; 43 (10): 1559-70
28. Coney P, Wasenik K, Langley RGB, et al. Weight change and adverse event incidence with a low-dose contraceptive: two randomised, placebo-controlled trials. Contraception 2001; 63: 297-302
29. Lynch NJ, Nimmo MA. Low dosage monophasic oral contraceptive use and intermittent exercise performance and metabolism in humans. Eur J Appl Physiol 2001; 84: 296-301
30. Casazza GA, Suh SH, Miller BF, et al. Effects of oral contraceptives on peak exercise capacity. J Appl Physiol 2002; 93: 1698-702
31. Tantbirojn P, Taneepanichskul S. Clinical comparative study of oral contraceptives containing 30μg ethinyestradiol/150μg levonorgestrel, and 35μg ethinyestradiol/250μg norgestimate in Thai women. Contraception 2002; 66: 401-5
32. Suh S, Casazza GA, Horning MA, et al. Effects of oral contraceptives on glucose flux and substrate oxidation rates during rest and exercise. J Appl Physiol 2003; 94: 285-94
33. Ruzic L, Matkovic BR, Leko G. Antiandrogens in hormonal contraception limit muscle strength gain in strength training: comparison study. Croat Med J 2003; 44 (1): 65-8
34. Elliot KJ, Cable NT, Reilly T. Does oral contraceptive use affect maximum force production in women? Br J Sports Med 2005; 39: 15-9
35. Jacobs KA, Casazza GA, Suh SH, et al. Fatty acid reesterification but not oxidation is increased by oral contraceptive use in women. J Appl Physiol 2005; 98: 1720-31
36. Redman LM, Scroop GC, Westlander G, et al. Effect of a synthetic progestin on the exercise status of sedentary young women. J Clin Endocrin Metab 2005; 90 (7): 3830-7
37. Laidlaw JC, Ruse JL, Gornall AG. The influence of estrogen and progesterone on aldosterone excretion. J Clin Endocrinol Metab 1962; 22: 161-71
38. Gaebelein CJ, Senay Jr LC. Vascular volume dynamics during ergometer exercise at different menstrual phases. Eur J Appl Physiol 1982; 50: 1-11
39. Stachenfeld NS, Taylor HS. Effects of oestrogen and progesterone administration on extracellular fluid. J Appl Physiol 2004; 96: 1011-8
40. Spruce BA, Baylis PH, Burd J, et al. Variation in osmoregulation of arginine vasopressin during the human menstrual cycle. Clin Endocrinol 1985; 22: 37-42
41. Houghton BL, Holowatz LA, Minson CT. Influence of progestin bioactivity on cutaneous vascular responses to passive heating. Med Sci Sports Exerc 2005; 37: 45-51
42. Charkoudian N, Johnson JM. Modification of active cutaneous vasodilation by oral contraceptive hormones. J Appl Physiol 1997; 83: 2012-8
43. Salkeld BD, MacAulay JC, Ball RW, et al. Modulation of body temperature, interleukin-6 and leptin by oral contraceptive use. Neuroimmunomodulation 2001; 9: 319-25
44. Kendrick ZV, Ellis GS. Effect of estradiol on tissue glycogen metabolism and lipid availability in exercised male rats. J Appl Physiol 1991; 71: 1694-9
45. Prange-Hansen A, Weeke J. Fasting serum growth hormone levels and growth hormone responses to exercise during normal menstrual cycles and cycles on contraceptives. Scand J Clin Lab Invest 1974; 34: 199-205
46. Diamond MP, Wentz AC, Cherrington AD. Alterations in carbohydrate metabolism as they apply to reproductive endocrinology. Fertil Steril 1988; 50: 387-97
47. Bonen A, Haynes FJ, Watson-Wright W, et al. Effects of the menstrual cycle on metabolic responses to exercise. J Appl Physiol 1983; 55: 1506-13
48. Bunt JC. Metabolic actions of estradiol: significance for acute and chronic exercise response. Med Sci Sports Exerc 1990; 22: 286-90
49. Hackney AC. Effects of the menstrual cycle on resting muscle glycogen content [abstract]. Horm Metab Res 1990; 22: 647
50. Ahmed-Sorour H, Bailey CJ. Role of the ovarian hormones in the long term control of glucose homeostasis, glycogen formation and gluconeogensis. Ann Nutr Metab 1981; 25: 208-12
51. Gillespy M, Notelovitz M, Ellington AB, et al. Effect of long-term triphasie oral contraceptive use on glucose tolerance and insulin secretion. Obstet Gynecol 1991; 78: 108-14
52. Godsland IF, Crook D, Simpson R, et al. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med 1990; 323 (20): 1375-81
53. Campbell SE, Angus DJ, Febbraio MA. Glucose kinetics and exercise performance during phases of the menstrual cycle: effect of glucose ingestion. Am J Physiol Endocrinol Metab 2001; 281: E817-25
54. Daggett A, Davies B, Boobis L. Physiological and biomechanical responses to exercise following oral contraceptive use [abstract]. Med Sci Sports Exerc 1983; 15: 174
55. Huisveld IA, Hospers JEH, Bernink MJE, et al. The effect of oral contraceptives and exercise on hemostatic and fibrinolytic mechanisms in training women. Int J Sports Med 1983; 4: 97-103
56. Littler WA, Bojorges-Buend R, Banks J. Cardiovascular dynamics in women during the menstrual cycle and oral contraceptive therapy. Thorax 1974; 29: 567-70
57. Willekes C, Hoogland HJ, Keizer HA, et al. Three months of third generation oral contraceptives does not affect artery wall properties. Ultrasound Med Biol 1999; 25: 723-8
58. Lehtovirta P, Kuikka J, Pyorala T. Hemodynamic effects of oral contraceptives during exercise. Int J Gynecol Obstet 1977; 15: 35-7
59. Walters WAW, Lim YL. Cardiovascular dynamics in women receiving oral contraceptive therapy. Lancet 1969; II: 879-81
60. De Bruyn-Prevost P, Masset C, Sturbois X. Physiological response from 18-25 years women to aerobic and anaerobic physical fitness tests at different periods during the menstrual cycle. J Sports Med 1984; 24: 144-8
61. McArdle WD, Katch FI, Katch VL. Exercise physiology. 5th ed. Champaign (IL): Human Kinetics, 2000
62. Phillips SK, Sanderson AG, Birch K, et al. Changes in maximal voluntary force of human adductor pollicis muscle during the menstrual cycle. J Physiol 1996; 496 (2): 551-7
63. Wirth JC, Lohman TG. The relationship of static muscle function to use of oral contraceptives. Med Sci Sports Exerc 1982; 14 (1): 18-20
64. Petrofsky JS, LeDonne DM, Rinehart JS, et al. Isometric strength and endurance during the menstrual cycle. Eur J Appl Physiol 1976; 35: 1-10
65. Stanczyk FZ. All progestins are not created equal. Steroids 2003; 68: 879-90
66. Savage KJ, Clarkson PM. Oral contraceptive use and exercise-induced muscle damage and recovery. Contraception 2002; 66: 67-71